Eric Aguiar, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 14,708 shares at $52.20 ($772K) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market sale of $772k BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.20 | 6,729 | $351K | 45.5% |
| 2 | $52.20 | 6,729 | $351K | 45.5% |
| 3 | $55.24 | 1,250 | $69K | 8.9% |
| Total | $52.46 avg | 14,708 | $772K | 100% |
| Filing → |
| NVTA | SELL | 2020-07-16 | $680K | — | Filing → |
| BHVN | SELL | 2020-01-24 | $114K | — | Filing → |
| BHVN | SELL | 2020-01-10 | $1.7M | — | Filing → |